Molecule Details
| InChIKey | OCAPBUJLXMYKEJ-UHFFFAOYSA-N |
|---|---|
| Compound Name | Bifonazole |
| Canonical SMILES | c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.42 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB04794 |
|---|---|
| Drug Name | Bifonazole |
| CAS Number | 60628-96-8 |
| Groups | approved |
| ATC Codes | D01AC10 D01AC60 |
| Description | Bifonazole is an azole antifungal drug. |
Categories: Anti-Infective Agents Antifungal Agents Antifungals for Dermatological Use Antifungals for Topical Use Azole Antifungals Cytochrome P-450 CYP2E1 Inhibitors Cytochrome P-450 CYP2E1 Inhibitors (strength unknown) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (weak) Cytochrome P-450 Enzyme Inhibitors Dermatologicals Imidazole and Triazole Derivatives
Cross-references: BindingDB: 50128548 ChEBI: 78692 CHEMBL277535 ChemSpider: 2287 PDB: TMI PharmGKB: PA164746464 PubChem:2378 PubChem:46507284 RxCUI: 19295 Therapeutic Targets Database: DAP000877 Wikipedia: Bifonazole